Ascendis Pharma A/S Ordinary Share Earnings Dividend

Ascendis Pharma A/S Ordinary Share’s revenue jumped 118.23% since last year same period to $344.9Mn in the Q2 2026. On a quarterly growth basis, Ascendis Pharma A/S Ordinary Share has generated 37.6% jump in its revenue since last 3-months.

Ascendis Pharma A/S Ordinary Share’s net profit jumped 641.49% since last year same period to $210.4Mn in the Q2 2026. On a quarterly growth basis, Ascendis Pharma A/S Ordinary Share has generated -67.11% fall in its net profits since last 3-months.

Ascendis Pharma A/S Ordinary Share’s net profit margin jumped 348.13% since last year same period to 61% in the Q2 2026. On a quarterly growth basis, Ascendis Pharma A/S Ordinary Share has generated -76.1% fall in its net profit margins since last 3-months.

Ascendis Pharma A/S Ordinary Share’s earning per share (EPS) estimates for the current quarter stand at 0.78 - a 81.4% jump from last quarter’s estimates.

Ascendis Pharma A/S Ordinary Share’s earning per share (EPS) estimates for the current year stand at 0.78.

Ascendis Pharma A/S Ordinary Share’s earning per share (EPS) jumped 453.76% since last year same period to 3.29 in the Q2 2026. This indicates that the Ascendis Pharma A/S Ordinary Share has generated 453.76% annual rate of jump in its earning per share (EPS) in the last 4 quarters.